Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 12:18 PM UTC
| NCT Number | NCT06313398 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Last Updated on CT.gov | February 24, 2026 (Feb 24, 2026) |
As of August 29, 2026: Clinical trial NCT06313398 is currently recruiting participants. This early_phase1 study for sickle cell disease is actively seeking new participants at 1 location across the United States. The study is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06313398 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06313398 was last updated Feb 24, 2026 (February 24, 2026). HelloStudys verifies this status automatically.